The determination of a legal settlement for “pain and suffering” is an exercise in creative accounting disguised as a moral verdict. A jury sits in a room, sequestered from the reality of the injury, and attempts to translate a shattered femur or a lost decade into a specific sequence of digits. They do not calculate the cost of the calcium; they do not audit the nervous system.
They pick a number that feels heavy enough to matter but light enough to be plausible. Usually, they start with whatever the lawyer shouted first. If the demand was ten million, they feel they have done their civic duty by landing at four. The four is not a derivation; it is a retreat from the ten.
A technical specification is a ghost. It is a boundary line drawn in a dark room by people who have never seen the light of the laboratory bench. In the world of high-stakes chemical procurement, we treat the certificate of analysis as a sacred text, but the numbers on that page are frequently the survivors of a commercial skirmish rather than the results of an experimental necessity.
We assume the “98%” was handed down from a principal investigator who calculated the exact tolerance of an assay. In reality, it was likely the point where a buyer’s exhaustion met a
